First-year biomedical graduate students across the country said labs have been hesitant to take them in due to a tenuous ...

The report claims “there is no evidence of benefit” from gender-affirming care for minors, while ignoring the many studies that show consistent short- and medium-term benefits. The report concludes ...

To be clear, there are laudable ideas, from a public health perspective, in the new guidelines. There is good reason to believe that ultra-processed foods (although difficult to define) are linked ...

Sanofi and Roche reported fourth-quarter and full-year 2025 earnings. Summit Therapeutics said the FDA accepted its application seeking approval of its PD-1/VEGF antibody ivonescimab to treat ...

This week on "The Readout LOUD": an in-depth discussion of UniQure's gene therapy for Huntington's disease and the high ...

A lawsuit from nine states seeks to undercut a federal mandate that people with disabilities receive care in their ...

AstraZeneca will invest $15 billion in China through 2030 to expand medicines manufacturing and research and development ...

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

A majority of respondents (67%) say Congress did the “wrong thing” by not yet extending the ACA enhanced premium tax credits, ...

How big of a role do our genes play in our lifespan? Quite a bit more than previously thought, a new study suggests.

The White House unveiled a new effort to streamline the country’s response to its drug and alcohol epidemic. But the announcement was light on details.

Ten technology vendors are offering $600 million worth of discounts to states that pick them to help implement Medicaid work requirements, the Trump administration announced Thursday, signaling how ...